Sponsor:
Ascentage Pharma Group Inc.
Code:
NCT07424833
Conditions
Relapsed/Refractory Hematological Malignancies
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL
Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation)
Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Relapsed/Refractory Waldenström Macroglobulinemia (WM)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
APG-3288
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-12. This information was provided to ClinicalTrials.gov by Ascentage Pharma Group Inc. on 2026-07-30.